Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Courten-Myers, G. M.
Right arrow Articles by Myers, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Courten-Myers, G. M.
Right arrow Articles by Myers, R. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CARBON DIOXIDE
*METHYLPREDNISOLONE
*OXYGEN

Stroke, Vol 25, 487-492, Copyright © 1994 by American Heart Association


ARTICLES

Efficacious experimental stroke treatment with high-dose methylprednisolone

GM de Courten-Myers, M Kleinholz, KR Wagner, G Xi and RE Myers
University of Cincinnati College of Medicine, Department of Pathology, OH 45267-0529.

BACKGROUND AND PURPOSE: Recent studies reveal success in treating spinal cord trauma with early, high-dose methylprednisolone. As in spinal cord research, failure to find therapeutic effects with steroids in studies of acute stroke treatment may reflect institution of treatment too late and at too low dosage. We presently test the efficacy of stroke treatment with methylprednisolone administered early and at high doses using a cat temporary middle cerebral artery occlusion model. METHODS: We occluded the middle cerebral artery for 4 hours in 24 pentobarbital-anesthetized cats. To enhance the probability of brain injury, we maintained the cats' serum glucose concentrations at high levels both during occlusion and for 6 hours afterward. Using a blinded, randomized study design, we treated 12 cats with methylprednisolone (30 mg/kg IV infused over 15 minutes starting 30 minutes after occlusion followed by 5.4 mg.kg-1.h-1 IV for the next 23 hours) and 12 control cats with vehicle. During and for 8 hours after occlusion, we monitored cerebral blood flow, brain and rectal temperatures, and multiple cardiovascular and blood compositional parameters. We assessed brain pathological outcome after animal survival for 4 days or after acute death from hemispheric edema. RESULTS: Experimental and control animals showed similar early mortality rates (treated, 3/12; controls, 4/12). However, surviving methylprednisolone-treated cats (n = 9) showed a mean infarct size more than six times smaller than in the control animals (n = 8) (mean +/- SEM, 2.4 +/- 0.7% versus 15.6 +/- 6.2% of the ischemic territory, respectively; P < .05). The methylprednisolone-treated animals also showed less marked reduction in cerebral blood flow during ischemia than did the controls (mean +/- SEM, 58 +/- 5% versus 74 +/- 4%; P < .005). CONCLUSIONS: Administering methylprednisolone at high doses early after onset of ischemia significantly reduces tissue injury in cats that survive 4 days of temporary middle cerebral artery occlusion. This improvement in outcome occurs in the setting of significant increases in ischemic cerebral blood flow. However, methylprednisolone treatment did not reduce hemispheric edema in animals that died early after temporary middle cerebral artery occlusion.


This article has been cited by other articles:


Home page
StrokeHome page
J. W. Norris
Steroids May Have a Role in Stroke Therapy
Stroke, January 1, 2004; 35(1): 228 - 229.
[Full Text] [PDF]


Home page
J. Physiol.Home page
C.-C. Liu, C.-H. Chien, and M.-T. Lin
Glucocorticoids reduce interleukin-1{beta} concentration and result in neuroprotective effects in rat heatstroke
J. Physiol., September 1, 2000; 527(2): 333 - 343.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. J. Becker, R. M. McCarron, C. Ruetzler, O. Laban, E. Sternberg, K. C. Flanders, and J. M. Hallenbeck
Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia
PNAS, September 30, 1997; 94(20): 10873 - 10878.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. R. Wagner, G. Xi, Y. Hua, M. Kleinholz, G. M. de Courten-Myers, R. E. Myers, J. P. Broderick, and T. G. Brott
Lobar Intracerebral Hemorrhage Model in Pigs : Rapid Edema Development in Perihematomal White Matter
Stroke, March 1, 1996; 27(3): 490 - 497.
[Abstract] [Full Text]